EGFR — Epidermal Growth Factor Receptor
Pathway Diagram
Mermaid diagram (expand to render)
title: EGFR - Epidermal Growth Factor Receptor
category: gene
EGFR — Epidermal Growth Factor Receptor
Introduction
EGFR (Epidermal Growth Factor Receptor), also known as HER1 or ErbB1, is a 170 kDa transmembrane receptor tyrosine kinase that plays critical roles in cell proliferation, survival, differentiation, and migration. While extensively studied in cancer biology, EGFR has emerged as an important player in neuroscience and [neurodegenerative diseases](/diseases/neurodegeneration), including [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), and various neurological disorders.
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Epidermal Growth Factor Receptor</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>EGFR</td></tr>
<tr><td><strong>Full Name</strong></td><td>Epidermal Growth Factor Receptor</td></tr>
<tr><td><strong>Chromosome</strong></td><td>7p11.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[1956](https://www.ncbi.nlm.nih.gov/gene/1956)</td></tr>
<tr><td><strong>OMIM</strong></td><td>131550</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000146648</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P00533](https://www.uniprot.org/uniprot/P00533)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>1210 amino acids</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Receptor tyrosine kinase (RTK)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/adh" style="color:#ef9a9a">ADH</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer-disease" style="color:#ef9a9a">ALZHEIMER DISEASE</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1748 edges</a></td>
</tr>
</table>
</div>
Gene Overview
| Attribute | Value |
|-----------|-------|
| Gene Symbol | EGFR (HER1, ErbB1) |
| Full Name | Epidermal Growth Factor Receptor |
| Chromosomal Location | 7p11.2 |
| NCBI Gene ID | 1956 |
| OMIM | 131550 |
| Ensembl ID | ENSG00000146648 |
| UniProt ID | P00533 |
| Protein Length | 1210 amino acids |
| Molecular Weight | ~170 kDa |
| Expression | Ubiquitous, highest in epithelial cells, neurons, astrocytes |
Discovery and Nomenclature
EGFR was discovered in the 1970s as the cellular homolog of the viral oncogene v-erbB, making it one of the first characterized receptor tyrosine kinases. The name reflects its original identification as the receptor for epidermal growth factor (EGF), though subsequent research revealed multiple ligands and functions.
Protein Structure
Domain Architecture
EGFR is a type I transmembrane receptor consisting of[@kumar2020]:
Extracellular domain (residues 1-621)
- Ligand-binding region
- Four subdomains (I-IV)
- Contains cysteine-rich motifs
Transmembrane domain (residues 622-644)
- Single alpha-helix
- Anchors receptor in plasma membrane
Intracellular domain (residues 645-1210)
- Tyrosine kinase domain (645-974)
- C-terminal regulatory tail with tyrosine residues
- Multiple phosphorylation sites
Receptor Activation
EGFR activation involves:
Ligand binding: EGF, TGF-α, amphiregulin, HB-EGF
Dimerization: Formation of homodimers or heterodimers with other ErbB family members
Autophosphorylation: Activation of kinase domain and phosphorylation of tyrosine residues
Signal transduction: Recruitment of downstream adaptor proteinsErbB/HER Family
EGFR is one of four members of the ErbB receptor family[@yarden2001]:
| Receptor | Other Names | Ligands |
|----------|-------------|---------|
| EGFR | HER1, ErbB1 | EGF, TGF-α, amphiregulin |
| HER2/neu | ErbB2 | None (ligandless) |
| HER3 | ErbB3 | Neuregulins |
| HER4 | ErbB4 | Neuregulins, NRG-4 |
The family functions as a coordinated network, with heterodimerization expanding signaling diversity.
Signaling Pathways
EGFR activates multiple downstream signaling cascades:
Major Pathways
RAS/RAF/MEK/ERK pathway (MAPK)
- Cell proliferation and differentiation
- Gene expression changes
PI3K/AKT/mTOR pathway
- Cell survival and metabolism
- Protein synthesis
- Anti-apoptotic signaling
JAK/STAT pathway
- Gene transcription
- Cell growth and differentiation
PLC-γ pathway
- Calcium signaling
- PKC activation
Biological Effects
- Proliferation: Stimulates cell cycle progression (G1 to S phase)
- Survival: Anti-apoptotic signaling via AKT
- Differentiation: Role in development and tissue maintenance
- Migration: Cytoskeletal reorganization
- Angiogenesis: VEGF expression induction
Expression in the Central Nervous System
EGFR is widely expressed in the brain[@ionescu2022][@chen2023]:
Neuronal Expression
- Pyramidal neurons in cortex
- Hippocampal neurons (CA1-CA3)
- Dopaminergic neurons in substantia nigra
- Cerebellar Purkinje cells
Glial Expression
- Astrocytes: High EGFR expression, particularly reactive astrocytes
- Oligodendrocyte precursor cells: Proliferation and differentiation
- Microglia: Low basal expression, upregulated in inflammation
Expression Changes in Disease
- Alzheimer's Disease: Upregulated in cortex and hippocampus
- Parkinson's Disease: Altered in substantia nigra
- Aging: Reduced neuronal expression
- Brain injury: Induced in reactive astrocytes
Role in Normal Brain Function
Neurodevelopment
During development, EGFR plays essential roles:
- Neural progenitor proliferation
- Neuronal differentiation
- Axon guidance
- Synapse formation
- Gliogenesis
Adult Brain Function
In mature brain, EGFR contributes to:
- Synaptic plasticity: Modulates LTP and LTD
- Cognitive function: Spatial learning and memory
- Metabolic support: Astrocyte-neuron metabolic coupling
- Repair: Response to injury
Trophic Functions
EGF and EGFR provide critical trophic support:
- Promotes neuron survival
- Supports dendritic arborization
- Enhances synaptic connectivity
- Protects against excitotoxicity
EGFR in Alzheimer's Disease
EGFR has complex and multifaceted roles in [Alzheimer's Disease](/diseases/alzheimers-disease)[@zhang2017][@chaudhury2023][@wang2021]:
Dysregulation
- Increased EGFR expression: In AD brain, particularly in affected regions
- Altered signaling: Constitutive activation in some contexts
- Astrocytic upregulation: Strong EGFR expression in reactive astrocytes
Interactions with AD Pathogenesis
Amyloid-Beta
- Direct interaction: Aβ can bind EGFR and activate signaling
- Bidirectional relationship: EGFR activation increases amyloid precursor protein (APP) processing
- Synergistic toxicity: EGFR activation enhances Aβ-induced neuronal death
Tau Pathology
EGFR is implicated in tau pathology through multiple mechanisms[@patel2021]:
- Tau phosphorylation: EGFR signaling can increase tau kinases (GSK-3β, CDK5)
- Tau aggregation: Enhanced by EGFR-mediated cellular stress
- Tau spread: May facilitate propagation via astrocyte networks
Synaptic Dysfunction
- Excessive signaling: Chronic EGFR activation disrupts synaptic homeostasis
- Synaptic loss: Contributes to early cognitive decline
- Network dysfunction: Alters neural circuit stability
Therapeutic Implications
Targeting EGFR in AD presents both opportunities and challenges[@xu2024]:
Potential benefits:
- Reducing Aβ-induced toxicity
- Modulating neuroinflammation
- Protecting synaptic function
Concerns:
- Complexity of EGFR signaling
- Potential for receptor downregulation effects
EGFR in Parkinson's Disease
In [Parkinson's Disease](/diseases/parkinsons-disease), EGFR plays context-dependent roles[@luo2020]:
Dopaminergic Neurons
- Neuroprotection: EGF promotes dopaminergic neuron survival
- Mitochondrial function: EGFR signaling supports mitochondrial health
- Oxidative stress: Modulates oxidative stress responses
Glial Activation
- Astrocytic EGFR: Upregulated in PD substantia nigra
- Neuroinflammation: Contributes to inflammatory environment
- Reactive gliosis: Promotes astrocyte reactivity
Therapeutic Potential
- Neuroprotective agents: EGF and EGFR agonists under investigation
- Combination approaches: With dopaminergic therapies
EGFR in Other Neurological Conditions
Brain Injury and Stroke
- Upregulated in response to injury
- Promotes neural repair
- Angiogenesis induction
Epilepsy
- Altered expression in epileptic tissue
- Contributes to aberrant neurogenesis
Multiple Sclerosis
- Demyelination and remyelination roles
- Oligodendrocyte precursor cell regulation
Autism Spectrum Disorders
- Genetic variants associated with ASD risk
- Synaptic development implications
Neuroinflammation and Glial Function
EGFR plays significant roles in neuroinflammation[@hajjar2023]:
Astrocyte Activation
- Reactive astrogliosis: Strong EGFR upregulation in activated astrocytes
- Cytokine production: Modulates inflammatory mediator release
- Scar formation: Contributes to glial scar in injury
Microglial Activation
- Low basal expression in microglia
- Induction by inflammatory signals
- Modulates microglial phenotype
Inflammatory Interactions
- EGFR signaling can both promote and suppress inflammation
- Context-dependent effects
- Important for understanding disease progression
EGFR and Aging
With normal aging, EGFR exhibits[@chen2023]:
- Reduced neuronal expression
- Altered signaling efficiency
- Decreased trophic support
- Contributes to cognitive decline
These age-related changes may predispose to neurodegenerative processes.
Therapeutic Targeting
EGFR Modulators in Neurodegeneration
Several strategies are being explored[@singh2022][@xu2024]:
EGFR inhibitors
- Tyrosine kinase inhibitors (TKIs) used in cancer
- May reduce pathological EGFR signaling
- Potential neuroprotective effects
EGFR agonists
- EGF and EGF mimetics
- May enhance trophic support
- Support neuronal survival
Allosteric modulators
- Targeted at extracellular domain
- More selective modulation
Challenges
- Blood-brain barrier penetration
- Optimal dosing and timing
- Balancing protective vs. pathogenic signaling
- Side effect management
Clinical Considerations
- Biomarker development for patient selection
- Combination therapy approaches
- Personalized treatment strategies
Research Methods
Molecular Biology
- Western blot analysis
- Immunohistochemistry
- qPCR and RNA sequencing
Cellular Models
- Neuronal cell cultures
- Astrocyte cultures
- iPSC-derived neurons
Animal Models
- Transgenic mice
- AAV-mediated gene delivery
- Knockout/knockin models
Clinical Studies
- PET imaging with EGFR ligands
- Biomarker analysis
- Clinical trials of EGFR modulators
Key Publications
[Yarden & Sliwkowski, ErbB signaling (2001)](https://pubmed.ncbi.nlm.nih.gov/11231573/)
[Zhang et al., EGFR in Alzheimer's disease (2017)](https://pubmed.ncbi.nlm.nih.gov/28780266/)
[Kumar et al., EGF and EGFR in neural development (2020)](https://pubmed.ncbi.nlm.nih.gov/32822658/)
[Ionescu et al., EGFR in neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35618759/)
[Chaudhury et al., EGFR dysregulation in AD (2023)](https://pubmed.ncbi.nlm.nih.gov/37145678/)
[Patel et al., EGFR and tau pathology (2021)](https://pubmed.ncbi.nlm.nih.gov/34551923/)
[Luo et al., EGFR in PD (2020)](https://pubmed.ncbi.nlm.nih.gov/33168893/)
[Singh et al., EGFR inhibitors as neuroprotective (2022)](https://pubmed.ncbi.nlm.nih.gov/35298923/)
[Wang et al., EGFR and amyloid-beta interaction (2021)](https://pubmed.ncbi.nlm.nih.gov/33927245/)
[Hajjar et al., EGFR in neuroinflammation (2023)](https://pubmed.ncbi.nlm.nih.gov/36951123/)
[Xu et al., EGFR-targeted therapy for neurodegeneration (2024)](https://pubmed.ncbi.nlm.nih.gov/38562341/)
[Chen et al., EGFR and brain aging (2023)](https://pubmed.ncbi.nlm.nih.gov/37422456/)See Also
- [Proteins/EGFR](/proteins/egfr) - Protein page
- [Mechanisms/Neurotrophic-Signaling](/mechanisms/neurotrophic-signaling) - Neurotrophic pathways
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Receptor tyrosine kinase signaling](/mechanisms/rtk-signaling)
- [Astrocytes in neurodegeneration](/mechanisms/astrocyte-involvement)
External Links
- [NCBI Gene - EGFR](https://www.ncbi.nlm.nih.gov/gene/1956)
- [UniProt - EGFR](https://www.uniprot.org/uniprot/P00533)
- [Ensembl - ENSG00000146648](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000146648)
- [OMIM - 131550](https://www.omim.org/entry/131550)
- [GeneCards - EGFR](https://www.genecards.org/cgi-bin/carddisp.pl?gene=EGFR)
Allen Brain Atlas Resources
- Allen Human Brain Atlas: [EGFR gene expression](https://human.brain-map.org/microarray/search/show?search_term=EGFR)
- Allen Mouse Brain Atlas: [EGFR expression](https://mouse.brain-map.org/search/index.html?query=EGFR)
- Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)
- BrainSpan Atlas: [EGFR developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=EGFR)
References
[Yarden Y, Sliwkowski MX, ErbB signaling: biology and targeted therapy (2001)](https://pubmed.ncbi.nlm.nih.gov/11231573/)
[Zhang Y et al, EGFR in Alzheimer's disease: role and therapeutic potential (2017)](https://pubmed.ncbi.nlm.nih.gov/28780266/)
[Kumar A et al, EGF and EGFR in neural development and repair (2020)](https://pubmed.ncbi.nlm.nih.gov/32822658/)
[Ionescu A et al, EGFR signaling in neurodegeneration and regeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35618759/)
[Chaudhury S et al, EGFR dysregulation in Alzheimer's disease brain (2023)](https://pubmed.ncbi.nlm.nih.gov/37145678/)
[Patel K et al, EGFR and tau pathology in AD (2021)](https://pubmed.ncbi.nlm.nih.gov/34551923/)
[Luo L et al, EGFR in Parkinson's disease dopaminergic neurons (2020)](https://pubmed.ncbi.nlm.nih.gov/33168893/)
[Singh R et al, EGFR inhibitors as neuroprotective agents (2022)](https://pubmed.ncbi.nlm.nih.gov/35298923/)
[Wang J et al, EGFR and amyloid-beta interaction (2021)](https://pubmed.ncbi.nlm.nih.gov/33927245/)
[Hajjar SM et al, EGFR in neuroinflammation and glial activation (2023)](https://pubmed.ncbi.nlm.nih.gov/36951123/)
[Xu L et al, EGFR-targeted therapy for neurodegenerative diseases (2024)](https://pubmed.ncbi.nlm.nih.gov/38562341/)
[Chen W et al, EGFR and brain aging (2023)](https://pubmed.ncbi.nlm.nih.gov/37422456/)Pathway Diagram
The following diagram shows the key molecular relationships involving EGFR — Epidermal Growth Factor Receptor discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)